Filing Details
- Accession Number:
- 0001104659-21-150678
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-16 19:46:50
- Reporting Period:
- 2021-12-14
- Accepted Time:
- 2021-12-16 19:46:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818382 | Humacyte Inc. | HUMA | Biological Products, (No Disgnostic Substances) (2836) | 851763759 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1878075 | E Laura Niklason | 2525 East North Carolina Highway 54 Durham NC 27713 | President, Ceo And Director | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-12-14 | 23,694 | $9.80 | 786,467 | No | 4 | S | Indirect | By spouse |
| Common Stock | Disposition | 2021-12-14 | 76,306 | $9.33 | 710,161 | No | 4 | S | Indirect | By spouse |
| Common Stock | Disposition | 2021-12-15 | 125,000 | $8.89 | 585,161 | No | 4 | S | Indirect | By spouse |
| Common Stock | Disposition | 2021-12-16 | 75,000 | $9.00 | 510,161 | No | 4 | S | Indirect | By spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By spouse |
| No | 4 | S | Indirect | By spouse |
| No | 4 | S | Indirect | By spouse |
| No | 4 | S | Indirect | By spouse |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 20,452,504 | Indirect | By Ayabudge LLC |
| Common Stock | 1,148,240 | Direct |
Footnotes
- A portion of this sale is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the purchase by Ayabudge LLC of 1,522,500 shares of the Issuer's common stock on August 26, 2021, at a price per share of $10.00. The Reporting Person's spouse has paid the Issuer $71.21, representing the full amount of profit realized in connection with this sale.
- The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $9.50 to $10.06. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.825 to $9.49. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.68 to $9.43. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.79 to $9.33. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
